NCT05395351View on ClinicalTrials.gov

Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization

CompletedOBSERVATIONAL
Enrollment

113,035

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

March 28, 2023

Study Completion Date

March 28, 2023

Conditions
Stroke
Interventions
DRUG

rt-PA

Intravenous recombinant tissue plasminogen activator (IV rt-PA)

Trial Locations (1)

200040

Boehringer Ingelheim (China) Investment Co., ltd., Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05395351 - Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization | Biotech Hunter | Biotech Hunter